All News

New research highlights the long-lasting effectiveness of mRNA COVID-19 vaccines, showing sustained B-cell and antibody responses in health care workers over 3 years.

Ronna Hauser, PharmD, senior vice president of policy and pharmacy affairs at NCPA, discussed concerns the association has with the implementation of the Medicare Drug Price Negotiation Plan.

Obecabtagene autoleucel improves CAR T-cell therapy for B-cell ALL.

This movement has aimed to address the mental health care epidemic in the United States.

The Version 3.2025 update adds tislelizumab-based regimens as preferred first-line treatments and introduces new dosing schedules for PD-L1–positive esophageal squamous cell carcinoma.

The smartphone application-led delabeling also did not delay surgeries or procedures in the evaluated clinics.

Clinicians should not just focus on one single nucleotide polymorphism (SNP), but rather consider all SNPs because each factor causes unique adverse effects

The announcement could ease the burden of prior authorizations on patients, which can cause unnecessary delays for patients receiving prescriptions and serious complications.

Recognizing pharmacy technicians as non-pharmacist preceptors can provide an opportunity for professional development while encouraging technicians to practice at the top of their education and training activities.

Thrombosis occurs in approximately 20% of myeloproliferative neoplasms.

The in vivo gene editing program is designed to eliminate cccDNA and inactive integrated hepatitis B DNA.

Experts attribute the increase of pertussis cases to declining DTaP vaccination rates.

Continuing education supports pharmacy technician career advancement, retention, and skill development.

A holistic approach emphasizing lifestyle modifications is essential to maintain weight loss after and while stopping medication.

Invasive pneumococcal disease trends have fluctuated greatly over the past 2 decades, with older adults remaining at the center of disease burden.

Host Craig Beavers spoke with Arthur Allen, PharmD, for the latest updates from the RIVAWAR trial and the newest ACS guidelines.

An oral dose of 0.6 mg per 5 mL of colchicine could aid individuals who have trouble with swallowing pills.

The meaningful results were reported in the DESTINY-Breast09 trial.

Although most health care professionals agree that patients do not need prescriptions for chronic diseases during end-of-life care, patients often receive them anyway.

The breakthrough designation is supported by clinical data from ongoing phase 1/2 trials.

In contrast to the study findings, the prescribing information for cefiderocol lists different common adverse effects.

Ronna Hauser, PharmD, senior vice president of policy and pharmacy affairs at NCPA, discusses concerns about the implementation of the MDPNP.

By implementing work practices alongside administrative and engineering controls, a safe and healthy work environment can be achieved.